{{Rsnum
|rsid=2574975
|Gene=SGMS1
|Chromosome=10
|position=52119297
|Orientation=minus
|GMAF=0.2925
|Gene_s=SGMS1
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 50.0 | 40.0 | 10.0
| HCB | 71.8 | 20.5 | 7.7
| JPT | 82.5 | 17.5 | 0.0
| YRI | 79.3 | 19.0 | 1.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 71.8 | 20.5 | 7.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=5E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}